Synergy is an innovative biopharmaceutical company specializing in cell therapy for oncology.
Synergy Therapeutics has raised $3.9M in total funding. The most recent round was Seed. The last funding was announced in September 2023.
Synergy Therapeutics is headquartered in Lugano, Switzerland.
Synergy is an innovative biopharmaceutical company specializing in cell therapy for oncology.
Synergy Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Synergy Therapeutics — Funding & Investors." VCBacked, September 8, 2023, https://www.vcbacked.co/company/synergy-therapeutics. Accessed August 1, 2026.
VCBacked. (2023). Synergy Therapeutics — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/synergy-therapeutics
{{cite web |title=Synergy Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/synergy-therapeutics |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated